Meredith Kaya | Director, Investor Relations |
Peter Hecht | Chief Executive Officer |
Tom McCourt | Chief Commercial Officer |
Mark Currie | Chief Scientific Officer |
Chris Wright | Chief Development Officer |
Gina Consylman | Interim Chief Financial Officer |
Ying Huang | Bank of America Merrill Lynch |
Boris Peaker | Cowen and Company |
Paul Choi | Barclays PLC |
Divya Harikesh | Goldman Sachs |
Anupam Rama | JP Morgan Chase & Co. |
Sara Slifka | Morgan Stanley |
Good day, ladies and gentlemen, and welcome to the Ironwood Pharmaceuticals Q3 2017 Investor Update Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded. I'd like to introduce your host for today's conference, Ms.